Cargando…
FKBPL: a novel prognostic and predictive biomarker?
Autores principales: | McKeen, HD, Byrne, C, Jithesh, PV, Donley, C, Yakkundi, A, McCallum, L, McCarthy, HO, Hirst, DG, Robson, T |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2875607/ http://dx.doi.org/10.1186/bcr2542 |
Ejemplares similares
-
Role of the Hsp90 cochaperone, FKBPL, in oestrogen receptor signalling and breast cancer growth and survival
por: McKeen, H, et al.
Publicado: (2008) -
The Anti-Migratory Effects of FKBPL and Its Peptide Derivative, AD-01: Regulation of CD44 and the Cytoskeletal Pathway
por: Yakkundi, Anita, et al.
Publicado: (2013) -
FKBPL Is a Critical Antiangiogenic Regulator of Developmental and Pathological Angiogenesis
por: Yakkundi, Anita, et al.
Publicado: (2015) -
FKBPL: a marker of good prognosis in breast cancer
por: Nelson, Laura, et al.
Publicado: (2015) -
FKBPL-based peptide, ALM201, targets angiogenesis and cancer stem cells in ovarian cancer
por: Annett, Stephanie, et al.
Publicado: (2019)